CoChat

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Open access
Morris, Gerwyn, Berk, Michael, Carvalho, André F., Maes, Michael, Walker, Adam J., Puri, Basant K. · 2018 · Behavioural Brain Research
Cited by 155

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Abstract

HighlightsFerroptosis is a major driver of cell death in neurodegenerative diseases e.g. AD.Oxidative and nitrosative stress adversely affect cellular iron homeostasis.Ferroptosis entails membrane lipid peroxidation and mitochondria involvement.Neuroinflammation and high NTBI levels make neuroglia sensitive to iron overload.Deferiprone with N‐acetylcysteine offers a rational therapeutic approach. Abstract Ferroptosis is a unique form of programmed death, characterised by cytosolic accumulation of iron, lipid hydroperoxides and their metabolites, and effected by the fatal peroxidation of polyunsaturated fatty acids in the plasma membrane. It is a major driver of cell death in neurodegenerative neurological diseases. Moreover, cascades underpinning ferroptosis could be active drivers of neuropathology in major psychiatric disorders. Oxidative and nitrosative stress can adversely affect mechanisms and proteins governing cellular iron homeostasis, such as the iron regulatory protein/iron response element system, and can ultimately be a source of abnormally high levels of iron and a source of lethal levels of lipid membrane peroxidation. Furthermore, neuroinflammation leads to the upregulation of divalent metal transporter1 on the surface of astrocytes, microglia and neurones, making them highly sensitive to iron overload in the presence of high levels of non‐transferrin‐bound iron, thereby affording such levels a dominant role in respect of the induction of iron‐mediated neuropathology. Mechanisms governing systemic and cellular iron homeostasis, and the related roles of ferritin and mitochondria are detailed, as are mechanisms explaining the negative regulation of ferroptosis by glutathione, glutathione peroxidase 4, the cysteine/glutamate antiporter system, heat shock protein 27 and nuclear factor erythroid 2‐related factor 2. The potential role of DJ‐1 inactivation in the precipitation of ferroptosis and the assessment of lipid peroxidation are described. Finally, a rational approach to therapy is considered, with a discussion on the roles of coenzyme Q10, iron chelation therapy, in the form of deferiprone, deferoxamine (desferrioxamine) and deferasirox, and N‐acetylcysteine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbr.2017.12.036

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 334

  1. Honig, 2000, Apoptosis and neurologic disease, Am. J. Med., 108, 317, 10.1016/S0002-9343(00)00291-6 · DOI · Paper page
  2. Belaidi, 2016, Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics, J. Neurochem., 139, 179, 10.1111/jnc.13425 · DOI · Paper page
  3. Guiney, 2017, Ferroptosis and cell death mechanisms in Parkinson's disease, Neurochem. Int., 104, 34, 10.1016/j.neuint.2017.01.004 · DOI · Paper page
  4. Andreazza, 2015, Oxidative stress in older patients with Bipolar Disorder, Am. J. Geriatr Psychiatry, 23, 314, 10.1016/j.jagp.2014.05.008 · DOI
  5. Wang, 2009, Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia, Bipolar Disord., 11, 523, 10.1111/j.1399-5618.2009.00717.x · DOI · Paper page
  6. Medina-Hernández, 2007, Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics, J. Psychiatr. Res., 41, 652, 10.1016/j.jpsychires.2006.02.010 · DOI
  7. Ramos-Loyo, 2013, Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 44, 154, 10.1016/j.pnpbp.2013.02.007 · DOI
  8. Selley, 2004, Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression, J. Affect. Disord., 80, 249, 10.1016/S0165-0327(03)00135-6 · DOI
  9. Romano, 2017, Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal, Free Radical Bio. Med., 111, 281, 10.1016/j.freeradbiomed.2016.12.046 · DOI
  10. Dixon, 2012, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
  11. Wang, 2016, Acetylation is crucial for p53-mediated ferroptosis and tumor suppression, Cell Rep., 17, 366, 10.1016/j.celrep.2016.09.022 · DOI · Paper page
  12. Yu, 2017, Ferroptosis, a new form of cell death, and its relationships with tumourous diseases, J. Cell Mol. Med., 21, 648, 10.1111/jcmm.13008 · DOI · Paper page
  13. Krainz, 2016, A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis, ACS Cent. Sci., 2, 653, 10.1021/acscentsci.6b00199 · DOI · Paper page
  14. Neitemeier, 2017, BID links ferroptosis to mitochondrial cell death pathways, Redox Biol., 12, 558, 10.1016/j.redox.2017.03.007 · DOI · Paper page
  15. Eng, 2010, Ammonia derived from glutaminolysis is a diffusible regulator of autophagy, Sci. Signal., 3, ra31, 10.1126/scisignal.2000911 · DOI · Paper page
  16. D'Herde, 2017, Ferroptosis: oxidized PEs trigger death, Nat. Chem. Biol., 13, 4, 10.1038/nchembio.2261 · DOI
  17. Kagan, 2017, Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis, Nat. Chem. Biol., 13, 81, 10.1038/nchembio.2238 · DOI · Paper page
  18. Andrews, 2007, Iron homeostasis, Annu. Rev. Physiol., 69, 69, 10.1146/annurev.physiol.69.031905.164337 · DOI · Paper page
  19. Lucas, 2015, The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue, CNS Neurol. Disord. Drug Targets, 14, 838, 10.2174/1871527314666150317224645 · DOI
  20. Morris, 2015, Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses, BMC Med., 13, 28, 10.1186/s12916-014-0259-2 · DOI · Paper page
  21. Morris, 2016, The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in neuroimmune disorders, Mol. Neurobiol, 53, 4638, 10.1007/s12035-015-9392-y · DOI · Paper page
  22. Nakamura, 2013, Aberrant protein s-nitrosylation in neurodegenerative diseases, Neuron, 78, 596, 10.1016/j.neuron.2013.05.005 · DOI · Paper page
  23. Linkermann, 2013, Necroptosis in immunity and ischemia-reperfusion injury, Am. J. Transplant., 13, 2797, 10.1111/ajt.12448 · DOI · Paper page
  24. Faux, 2014, An anemia of Alzheimer's disease, Mol. Psychiatry, 19, 1227, 10.1038/mp.2013.178 · DOI
  25. Gangania, 2017, Role of iron and copper in the pathogenesis of Parkinson's disease, Indian J. Clinical Biochem.: IJCB, 32, 353, 10.1007/s12291-016-0614-5 · DOI
  26. Camaschella, 2013, Iron and hepcidin: a story of recycling and balance, Hematol. Am. Soc. Hematol. Educ. Program, 1
  27. Kasvosve, 2013, Effect of ferroportin polymorphism on iron homeostasis and infection, Clin. Chim. Acta, 416, 20, 10.1016/j.cca.2012.11.013 · DOI
  28. Millonig, 2012, Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3), The Journal of biological chemistry, 287, 37472, 10.1074/jbc.M112.358911 · DOI · Paper page
  29. Laftah, 2008, Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1), Br. J. Nutr., 101, 1150, 10.1017/S0007114508066762 · DOI · Paper page
  30. Garrick, 2009, Cellular iron transport, Biochim. Biophys. Acta, 1790, 309, 10.1016/j.bbagen.2009.03.018 · DOI
  31. Arosio, 2010, Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage, Biochim. Biophys. Acta, 1800, 783, 10.1016/j.bbagen.2010.02.005 · DOI · Paper page
  32. Zhao, 2006, Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study, Biochemistry, 45, 3429, 10.1021/bi052443r · DOI · Paper page
  33. Argaw, 2006, IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program, J. Immunol., 177, 5574, 10.4049/jimmunol.177.8.5574 · DOI · Paper page
  34. Stehling, 2014, Mitochondrial iron-sulfur protein biogenesis and human disease, Biochimie, 100, 61, 10.1016/j.biochi.2014.01.010 · DOI · Paper page
  35. Stehling, 2013, The role of mitochondria in cellular iron–sulfur protein biogenesis: mechanisms, connected processes, and diseases, Cold Spring Harb. Perspect. Biol., 5, a011312, 10.1101/cshperspect.a011312 · DOI · Paper page
  36. Paradkar, 2009, Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2, Mol. Cell. Biol., 29, 1007, 10.1128/MCB.01685-08 · DOI · Paper page
  37. Rouault, 2016, Mitochondrial iron overload: causes and consequences, Curr. Opin. Genet. Dev., 38, 31, 10.1016/j.gde.2016.02.004 · DOI · Paper page
  38. Martelli, 2015, Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency, Cell Metab., 21, 311, 10.1016/j.cmet.2015.01.010 · DOI
  39. Bencze, 2007, Human frataxin: iron and ferrochelatase binding surface, Chem. Commun. (Cambridge, England), 1798, 10.1039/B703195E · DOI · Paper page
  40. Tsai, 2010, Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex, Biochemistry, 49, 9132, 10.1021/bi1013062 · DOI · Paper page
  41. Lefevre, 2012, Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells, Biochem. Biophys. Res. Commun., 418, 336, 10.1016/j.bbrc.2012.01.022 · DOI
  42. Bou-Abdallah, 2005, Unique iron binding and oxidation properties of human mitochondrial ferritin: a comparative analysis with human H-chain ferritin, J. Mol. Biol., 347, 543, 10.1016/j.jmb.2005.01.007 · DOI
  43. Gao, 2014, Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases, Front. Pharmacol., 5, 19, 10.3389/fphar.2014.00019 · DOI · Paper page
  44. Nie, 2005, Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis, Blood, 105, 2161, 10.1182/blood-2004-07-2722 · DOI · Paper page
  45. Moos, 2007, Iron trafficking inside the brain, J. Neurochem., 103, 1730, 10.1111/j.1471-4159.2007.04976.x · DOI · Paper page
  46. Rouault, 2009, Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins, Metab. Brain Dis., 24, 673, 10.1007/s11011-009-9169-y · DOI · Paper page
  47. Simpson, 2015, A novel model for brain iron uptake: introducing the concept of regulation, J. Cereb. Blood Flow Metab., 35, 48, 10.1038/jcbfm.2014.168 · DOI · Paper page
  48. McCarthy, 2014, Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells, PloS One, 9, e89003, 10.1371/journal.pone.0089003 · DOI
  49. McCarthy, 2015, Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy, Cell. Mol. Life Sci.: CMLS, 72, 709, 10.1007/s00018-014-1771-4 · DOI · Paper page
  50. Codazzi, 2015, Iron entry in neurons and astrocytes: a link with synaptic activity, Front. Mol. Neurosci., 8, 10.3389/fnmol.2015.00018 · DOI · Paper page
  51. Ji, 2015, Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons, J. Neurochem., 133, 668, 10.1111/jnc.13040 · DOI · Paper page
  52. Hohnholt, 2013, Uptake and metabolism of iron and iron oxide nanoparticles in brain astrocytes, Biochem. Soc. Trans., 41, 1588, 10.1042/BST20130114 · DOI · Paper page
  53. Pelizzoni, 2013, Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden, Biochim. Biophys. Acta, 1832, 1326, 10.1016/j.bbadis.2013.04.007 · DOI · Paper page
  54. Liu, 2017, Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance, Sci. Rep., 7, 14973, 10.1038/s41598-017-14721-1 · DOI
  55. Zhang, 2012, Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses, Haematologica, 97, 1826, 10.3324/haematol.2012.063974 · DOI
  56. Skjorringe, 2015, Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology, Front. Mol. Neurosci., 8, 19
  57. Richardson, 2004, The transferrin homologue, melanotransferrin (p97), is rapidly catabolized by the liver of the rat and does not effectively donate iron to the brain, Biochim. Biophys. Acta, 1690, 124, 10.1016/j.bbadis.2004.06.002 · DOI
  58. Musci, 2014, Ceruloplasmin-ferroportin system of iron traffic in vertebrates, World J. Biol. Chem., 5, 204, 10.4331/wjbc.v5.i2.204 · DOI · Paper page
  59. Vashchenko, 2013, Multi-copper oxidases and human iron metabolism, Nutrients, 5, 2289, 10.3390/nu5072289 · DOI · Paper page
  60. Singh, 2014, Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities, Antioxid. Redox Signal., 20, 1324, 10.1089/ars.2012.4931 · DOI · Paper page
  61. Pelizzoni, 2011, Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity, Aging Cell, 10, 172, 10.1111/j.1474-9726.2010.00652.x · DOI · Paper page
  62. Pelizzoni, 2012, Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx, J. Neurochem., 120, 269, 10.1111/j.1471-4159.2011.07578.x · DOI · Paper page
  63. Li, 2011, Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury, Acta Pharmacol. Sinica, 32, 734, 10.1038/aps.2011.47 · DOI
  64. Chen, 2013, Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity, J. Neurosci., 33, 3582, 10.1523/JNEUROSCI.1497-12.2013 · DOI
  65. Huang, 2006, Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury, Exp. Brain Res., 170, 376, 10.1007/s00221-005-0220-x · DOI
  66. Wang, 2010, Selective neuronal vulnerability to oxidative stress in the brain, Front. Aging Neurosci., 2
  67. Rathore, 2012, Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1, Glia, 60, 738, 10.1002/glia.22303 · DOI · Paper page
  68. You, 2017, Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis, Cell. Death Dis., 8, e2676, 10.1038/cddis.2017.93 · DOI · Paper page
  69. Zhang, 2014, The physiological functions of iron regulatory proteins in iron homeostasis - an update, Front. Pharmacol., 5, 10.3389/fphar.2014.00124 · DOI · Paper page
  70. Bornsen, 2015, Endogenous interferon-beta-inducible gene expression and interferon-beta-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis, PloS One, 10, e0118830, 10.1371/journal.pone.0118830 · DOI
  71. Caltagirone, 2001, Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts, J. Biol. Chem., 276, 19738, 10.1074/jbc.M100245200 · DOI · Paper page
  72. Eisenstein, 2003, Novel roles for iron regulatory proteins in the adaptive response to iron deficiency, J. Nutr., 133, 1510s, 10.1093/jn/133.5.1510S · DOI
  73. Pantopoulos, 1995, Rapid responses to oxidative stress mediated by iron regulatory protein, EMBO J., 14, 2917, 10.1002/j.1460-2075.1995.tb07291.x · DOI · Paper page
  74. Chen, 1997, Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver, J. Nutr., 127, 238, 10.1093/jn/127.2.238 · DOI
  75. Meyron-Holtz, 2004, Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo, Science (New York, N.Y.), 306, 2087, 10.1126/science.1103786 · DOI · Paper page
  76. Stys, 2011, Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide, J. Biol. Chem., 286, 22846, 10.1074/jbc.M111.231902 · DOI · Paper page
  77. Kim, 2002, Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis, Blood Cells Mol. Dis., 29, 400, 10.1006/bcmd.2002.0579 · DOI
  78. Mikhael, 2006, Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide, FEBS J., 273, 3828, 10.1111/j.1742-4658.2006.05390.x · DOI · Paper page
  79. Cairo, 2002, Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase, Biochemistry, 41, 7435, 10.1021/bi025756k · DOI · Paper page
  80. Soum, 2003, Peroxynitrite and nitric oxide differently target the iron-sulfur cluster and amino acid residues of human iron regulatory protein 1, Biochemistry, 42, 7648, 10.1021/bi030041i · DOI · Paper page
  81. Conrad, 2012, The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-) : cystine supplier and beyond, Amino Acids, 42, 231, 10.1007/s00726-011-0867-5 · DOI · Paper page
  82. Lall, 2008, Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase, Invest. Ophthalmol. Vis. Sci., 49, 310, 10.1167/iovs.07-1041 · DOI
  83. Maria, 2013, Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy, Int. J. Clin. Exp. Med., 6, 50
  84. Kalgaonkar, 2009, Receptor-mediated uptake of ferritin-bound iron by human intestinal Caco-2 cells, J. Nutr. Biochem., 20, 304, 10.1016/j.jnutbio.2008.04.003 · DOI
  85. Li, 2010, Binding and uptake of H-ferritin are mediated by human transferrin receptor-1, Proc. Natl. Acad. Sci. U. S. A., 107, 3505, 10.1073/pnas.0913192107 · DOI · Paper page
  86. Watanabe, 2001, Iron content of rat serum ferritin, J. Vet. Med. Sci., 63, 587, 10.1292/jvms.63.587 · DOI
  87. Hintze, 2005, DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression, Proc. Natl. Acad. Sci. U. S. A., 102, 15048, 10.1073/pnas.0505148102 · DOI · Paper page
  88. Vile, 1994, Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 91, 2607, 10.1073/pnas.91.7.2607 · DOI · Paper page
  89. Vile, 1993, Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin, J. Biol. Chem., 268, 14678, 10.1016/S0021-9258(18)82386-9 · DOI · Paper page
  90. Boyle, 2011, Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage, Arterioscler. Thromb. Vasc. Biol., 31, 2685, 10.1161/ATVBAHA.111.225813 · DOI · Paper page
  91. Reichard, 2007, Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1, Nucleic Acids Res., 35, 7074, 10.1093/nar/gkm638 · DOI · Paper page
  92. Lu, 2009, Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism, Antioxid. Redox Signal., 11, 1791, 10.1089/ars.2008.2306 · DOI
  93. Liu, 2013, Carbonylation of mitochondrial aconitase with 4-hydroxy-2-(E)-nonenal: localization and relative reactivity of addition sites, Biochim. Biophys. Acta, 1834, 1144, 10.1016/j.bbapap.2013.03.005 · DOI
  94. Singh, 2008, Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice, Biochemistry, 47, 3900, 10.1021/bi702124u · DOI · Paper page
  95. Paradies, 2010, Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease, J. Pineal Research, 48, 297, 10.1111/j.1600-079X.2010.00759.x · DOI · Paper page
  96. Paradies, 1999, Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion, Free Radical Biol. Med., 27, 42, 10.1016/S0891-5849(99)00032-5 · DOI · Paper page
  97. Sen, 2006, Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria, Neurochem. Int., 49, 20, 10.1016/j.neuint.2005.12.018 · DOI
  98. Pizzimenti, 2013, Interaction of aldehydes derived from lipid peroxidation and membrane proteins, Front. Physiol., 4, 10.3389/fphys.2013.00242 · DOI · Paper page
  99. Chen, 1994, Alterations in mitochondrial membrane fluidity by lipid peroxidation products, Free Radical Biol. Med., 17, 411, 10.1016/0891-5849(94)90167-8 · DOI · Paper page
  100. Rosales-Corral, 2012, Alterations in lipid levels of mitochondrial membranes induced by amyloid-β A protective role of melatonin, Int. J. Alzheimer’s Dis., 14
  101. Betaneli, 2012, The role of lipids in VDAC oligomerization, Biophys. J., 102, 523, 10.1016/j.bpj.2011.12.049 · DOI
  102. Hedger, 2016, Lipid-loving ANTs: molecular simulations of cardiolipin interactions and the organization of the adenine nucleotide translocase in model mitochondrial membranes, Biochemistry, 55, 6238, 10.1021/acs.biochem.6b00751 · DOI · Paper page
  103. Montero, 2010, Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death, Biochim. Biophys. Acta, 1797, 1217, 10.1016/j.bbabio.2010.02.010 · DOI · Paper page
  104. Musatov, 2006, Contribution of peroxidized cardiolipin to inactivation of bovine heart cytochrome c oxidase, Free Radical Biol. Med., 41, 238, 10.1016/j.freeradbiomed.2006.03.018 · DOI
  105. Raemy, 2014, Involvement of cardiolipin in tBID-induced activation of BAX during apoptosis, Chem. Phys. Lipids, 179, 70, 10.1016/j.chemphyslip.2013.12.002 · DOI
  106. Shamas-Din, 2015, Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax, Biochem. J., 467, 495, 10.1042/BJ20141291 · DOI · Paper page
  107. Galam, 2015, 4-Hydroxynonenal regulates mitochondrial function in human small airway epithelial cells, Oncotarget, 6, 41508, 10.18632/oncotarget.6131 · DOI
  108. Zhong, 2015, Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria, Redox Biol., 4, 193, 10.1016/j.redox.2014.12.011 · DOI · Paper page
  109. Fukai, 2011, Superoxide dismutases: role in redox signaling, vascular function, and diseases, Antioxid. Redox Signal., 15, 1583, 10.1089/ars.2011.3999 · DOI · Paper page
  110. Kim, 2008, Regulation of pro-inflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo, Exp. Mol. Med., 40, 461, 10.3858/emm.2008.40.4.461 · DOI
  111. Lee, 2011, Mitochondrial H2O2 generated from electron transport chain complex I stimulates muscle differentiation, Cell Res., 21, 817, 10.1038/cr.2011.55 · DOI · Paper page
  112. Schaur, 2015, 4-Hydroxy-nonenal—A bioactive lipid peroxidation product, Biomolecules, 5, 2247, 10.3390/biom5042247 · DOI · Paper page
  113. Chuang, 2015, Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway, J. Neuroinflammation, 12, 199, 10.1186/s12974-015-0419-0 · DOI · Paper page
  114. Shibata, 2011, 4-Hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A(2) in cultured Ra2 microglial cells via MAPK pathways, Neuropathology, 31, 122, 10.1111/j.1440-1789.2010.01139.x · DOI
  115. Zhu, 2009, NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2, Biochem. J., 421, 201, 10.1042/BJ20090356 · DOI
  116. Sun, 2014, Role of cytosolic phospholipase A(2) in oxidative and inflammatory signaling pathways in different cell types in the central nervous system, Mol. Neurobiol., 50, 6, 10.1007/s12035-014-8662-4 · DOI · Paper page
  117. Conrad, 2010, 12/15-lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases, Proc. Nat. Acad. Sci. U. S. A., 107, 15774, 10.1073/pnas.1007909107 · DOI · Paper page
  118. Hermann, 2014, Phospholipase A2 – nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? insights from a snail model system of neuronal aging and age-associated memory impairment, Front. Genet., 5, 10.3389/fgene.2014.00419 · DOI
  119. Chen, 2005, Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity, Diabetologia, 48, 486, 10.1007/s00125-005-1673-y · DOI
  120. Slomiany, 2009, Involvement of constitutive nitric oxide synthase in ghrelin-induced cytosolic phospholipase A(2) activation in gastric mucosal cell protection against ethanol cytotoxicity, Inflammopharmacology, 17, 245, 10.1007/s10787-009-0013-0 · DOI
  121. Doll, 2017, Iron and ferroptosis: A still ill-defined liaison, IUBMB Life, 69, 423, 10.1002/iub.1616 · DOI · Paper page
  122. Guaraldo, 2016, Characterization of human mitochondrial ferritin promoter: identification of transcription factors and evidences of epigenetic control, Sci. Rep., 6, 33432, 10.1038/srep33432 · DOI
  123. Yang, 2013, Mitochondrial ferritin in neurodegenerative diseases, Neurosci. Res., 77, 1, 10.1016/j.neures.2013.07.005 · DOI · Paper page
  124. Chaum, 2009, Quantitative AP-1 gene regulation by oxidative stress in the human retinal pigment epithelium, J. Cell. Biochem., 108, 1280, 10.1002/jcb.22358 · DOI
  125. Invernizzi, 2013, Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors, Br. J. Haematol., 161, 726, 10.1111/bjh.12316 · DOI
  126. Santambrogio, 2011, Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation, Haematologica, 96, 1424, 10.3324/haematol.2011.042952 · DOI
  127. Bresgen, 2010, Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death, Free Radical Biol. Med., 48, 1347, 10.1016/j.freeradbiomed.2010.02.019 · DOI
  128. Antunes, 2001, Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture, Biochem. J., 356, 549, 10.1042/bj3560549 · doi:10.1042/bj3560549 · Paper page
  129. Kurz, 2011, The role of lysosomes in iron metabolism and recycling, Int. J. Biochem. Cell Biol., 43, 1686, 10.1016/j.biocel.2011.08.016 · DOI · Paper page
  130. Yu, 2003, Intralysosomal iron: a major determinant of oxidant-induced cell death, Free Radical Biol. Med., 34, 1243, 10.1016/S0891-5849(03)00109-6 · DOI · Paper page
  131. Zdolsek, 1993, Effect of reactive oxygen species on lysosomal membrane integrity. A study on a lysosomal fraction, Virchows Archiv. B, 64, 401, 10.1007/BF02915141 · DOI
  132. Hyun, 2002, Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration?, J. Neurochem., 83, 360, 10.1046/j.1471-4159.2002.01125.x · DOI · Paper page
  133. Krohne, 2010, Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action, Exp. Eye Res., 90, 261, 10.1016/j.exer.2009.10.014 · DOI
  134. Okada, 1999, 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules, J. Biol. Chem., 274, 23787, 10.1074/jbc.274.34.23787 · DOI · Paper page
  135. Casañas-Sanchez, 2015, Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells, Front. Physiol., 6, 10.3389/fphys.2015.00203 · DOI
  136. Fruhwirth, 2008, Mediation of apoptosis by oxidized phospholipids, Sub-Cell. Biochem., 49, 351, 10.1007/978-1-4020-8831-5_13 · DOI
  137. Volinsky, 2013, Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology, FEBS J., 280, 2806, 10.1111/febs.12247 · DOI
  138. Singh, 2010, Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein, J. Alzheimers Dis., 21, 741, 10.3233/JAD-2010-100405 · DOI · Paper page
  139. Ishikado, 2013, 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation, PloS One, 8, e69415, 10.1371/journal.pone.0069415 · DOI
  140. Kusunoki, 2013, Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 430, 225, 10.1016/j.bbrc.2012.10.115 · DOI
  141. Yang, 2013, Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-kappaB pathways, J. Nutrit. Biochem., 24, 204, 10.1016/j.jnutbio.2012.05.003 · DOI
  142. Nguyen, 2009, The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress, J. Biol. Chem., 284, 13291, 10.1074/jbc.R900010200 · DOI · Paper page
  143. Habib, 2015, Expression of xCT and activity of system x(c)(−) are regulated by NRF2 in human breast cancer cells in response to oxidative stress, Redox Biol., 5, 33, 10.1016/j.redox.2015.03.003 · DOI · Paper page
  144. Qiang, 2004, Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes, J. Virol., 78, 11926, 10.1128/JVI.78.21.11926-11938.2004 · DOI · Paper page
  145. Griffith, 1999, Biologic and pharmacologic regulation of mammalian glutathione synthesis, Free Radical Biol. Med., 27, 922, 10.1016/S0891-5849(99)00176-8 · DOI · Paper page
  146. Franco, 2007, The central role of glutathione in the pathophysiology of human diseases, Arch. Physiol. Biochem., 113, 234, 10.1080/13813450701661198 · DOI · Paper page
  147. Awasthi, 2008, Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death, Free Radical Biol. Med., 45, 10.1016/j.freeradbiomed.2008.04.007 · DOI
  148. Singhal, 2015, Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling, Toxicol. Appl. Pharmacol., 289, 361, 10.1016/j.taap.2015.10.006 · DOI · Paper page
  149. Balogh, 2011, Interactions of glutathione transferases with 4-hydroxynonenal, Drug Metab. Rev., 43, 165, 10.3109/03602532.2011.558092 · DOI · Paper page
  150. Homolya, 2003, Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate, BioFactors (Oxford, England), 17, 103, 10.1002/biof.5520170111 · DOI · Paper page
  151. Morris, 2014, The glutathione system: a new drug target in neuroimmune disorders, Mol. Neurobiol., 50, 1059, 10.1007/s12035-014-8705-x · DOI · Paper page
  152. Bridges, 2012, System x(c)(-) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS, Br. J. Pharmacol., 165, 20, 10.1111/j.1476-5381.2011.01480.x · DOI · Paper page
  153. Lewerenz, 2013, The cystine/glutamate antiporter system x(c)(−) in health and disease: from molecular mechanisms to novel therapeutic opportunities, Antioxid. Redox Signal., 18, 522, 10.1089/ars.2011.4391 · DOI · Paper page
  154. Pampliega, 2011, Increased expression of cystine/glutamate antiporter in multiple sclerosis, J. Neuroinflammation, 8, 63, 10.1186/1742-2094-8-63 · DOI · Paper page
  155. Anderson, 2012, Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart, Clin. Exp. Pharmacol. Physiol., 39, 10.1111/j.1440-1681.2011.05641.x · DOI · Paper page
  156. Imai, 2003, Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells, Free radical biology & medicine, 34, 145, 10.1016/S0891-5849(02)01197-8 · DOI · Paper page
  157. Yu, 2014, Characterization and structural analysis of human selenium-dependent glutathione peroxidase 4 mutant expressed in Escherichia coli, Free Radical Biol. Med., 71, 332, 10.1016/j.freeradbiomed.2014.03.032 · DOI
  158. Arrigo, 2005, Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels, Antioxid. Redox Signal., 7, 414, 10.1089/ars.2005.7.414 · DOI · Paper page
  159. Chen, 2006, Heat shock protein 27 downregulates the transferrin receptor 1-mediated iron uptake, Int. J. Biochem. Cell Biol., 38, 1402, 10.1016/j.biocel.2006.02.006 · DOI
  160. Mehlen, 1997, Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells, Biochem. Biophys. Res. Commun., 241, 187, 10.1006/bbrc.1997.7635 · doi:10.1006/bbrc.1997.7635
  161. Ullrich, 1994, Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex, FEBS Lett., 352, 84, 10.1016/0014-5793(94)00922-8 · DOI · Paper page
  162. Savaskan, 2007, Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function, Biol. Chem., 388, 1007, 10.1515/BC.2007.126 · DOI · Paper page
  163. Brigelius-Flohe, 1994, Phospholipid-hydroperoxide glutathione peroxidase. Genomic DNA, cDNA, and deduced amino acid sequence, J. B. Chem., 269, 7342, 10.1016/S0021-9258(17)37290-3 · DOI · Paper page
  164. Antunes, 1995, PHGPx and phospholipase A2/GPx: comparative importance on the reduction of hydroperoxides in rat liver mitochondria, Free Radical Biol. Med., 19, 669, 10.1016/0891-5849(95)00040-5 · DOI
  165. Scheerer, 2007, Structural basis for catalytic activity and enzyme polymerization of phospholipid hydroperoxide glutathione peroxidase-4 (GPx4), Biochemistry, 46, 9041, 10.1021/bi700840d · DOI · Paper page
  166. Imai, 1996, Overexpression of phospholipid hydroperoxide glutathione peroxidase suppressed cell death due to oxidative damage in rat basophile leukemia cells (RBL-2H3), Biochem. Biophys. Res. Commun., 222, 432, 10.1006/bbrc.1996.0762 · DOI
  167. Yagi, 1996, Expression of human phospholipid hydroperoxide glutathione peroxidase gene for protection of host cells from lipid hydroperoxide-mediated injury, Biochem. Biophys. Res. Commun., 219, 486, 10.1006/bbrc.1996.0260 · DOI
  168. Brigelius-Flohe, 2000, Overexpression of PHGPx inhibits hydroperoxide-induced oxidation, NFkappaB activation and apoptosis and affects oxLDL-mediated proliferation of rabbit aortic smooth muscle cells, Atherosclerosis, 152, 307, 10.1016/S0021-9150(99)00486-4 · DOI
  169. Arai, 1999, Mitochondrial phospholipid hydroperoxide glutathione peroxidase plays a major role in preventing oxidative injury to cells, J. Biol. Chem., 274, 4924, 10.1074/jbc.274.8.4924 · DOI · Paper page
  170. Liang, 2007, Gpx4 protects mitochondrial ATP generation against oxidative damage, Biochem. Biophys. Res. Commun., 356, 893, 10.1016/j.bbrc.2007.03.045 · DOI
  171. Ran, 2006, Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity, J. Neurosci. Res., 84, 202, 10.1002/jnr.20868 · DOI · Paper page
  172. Kaspar, 2010, An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance, J. Biol. Chem., 285, 21349, 10.1074/jbc.M110.121863 · DOI
  173. Milani, 2013, SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration, Oxidative Med. Cell. Longevity, 836760
  174. Lev, 2008, Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection, Neurotoxicology, 29, 397, 10.1016/j.neuro.2008.01.007 · DOI
  175. Shadrach, 2013, DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE), PloS One, 8, e67983, 10.1371/journal.pone.0067983 · DOI
  176. Liu, 2014, Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV–A- induced apoptosis in corneal endothelial Cells, Invest. Ophthalmol. Vis. Sci., 55, 5551, 10.1167/iovs.14-14580 · DOI
  177. Saidu, 2017, Dimethyl fumarate controls the NRF2/DJ-1 axis in cancer cells: therapeutic applications, Mol. Cancer Ther., 16, 529, 10.1158/1535-7163.MCT-16-0405 · DOI
  178. Ishikawa, 2010, Human DJ-1-specific transcriptional activation of tyrosine hydroxylase Gene, J. Biol. Chem., 285, 39718, 10.1074/jbc.M110.137034 · DOI
  179. Wilson, 2011, The role of cysteine oxidation in DJ-1 function and dysfunction, Antioxid. Redox Signal., 15, 111, 10.1089/ars.2010.3481 · DOI · Paper page
  180. Cao, 2014, The oxidation states of DJ-1 dictate the cell fate in response to oxidative stress triggered by 4-hpr: autophagy or apoptosis?, Antioxid. Redox Signal., 21, 1443, 10.1089/ars.2013.5446 · DOI
  181. Ito, 2006, Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1, Biochem. Biophys. Res. Commun., 339, 667, 10.1016/j.bbrc.2005.11.058 · DOI
  182. Alary, 1995, Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat, Chem. Res. Toxicol., 8, 34, 10.1021/tx00043a004 · DOI · Paper page
  183. Alary, 2003, Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat, Chem. Res. Toxicol., 16, 320, 10.1021/tx025671k · DOI
  184. Alary, 2003, Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways, Mol. Aspects Med., 24, 177, 10.1016/S0098-2997(03)00012-8 · DOI
  185. Keller, 2015, “Twin peaks”: searching for 4-hydroxynonenal urinary metabolites after oral administration in rats, Redox Biol., 4, 136, 10.1016/j.redox.2014.12.016 · doi:10.1016/j.redox.2014.12.016
  186. Selley, 1989, Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometry, J. Chromatogr., 488, 329, 10.1016/S0378-4347(00)82957-6 · DOI
  187. Mishra, 2013, Iron overload in Beta thalassaemia major and intermedia patients, Mædica, 8, 328
  188. Novembrino, 2005, Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-ferritin (Abbott) assay, Clin. Chem. Lab. Med., 43, 449, 10.1515/CCLM.2005.079 · DOI
  189. Camaschella, 2009, Towards explaining "unexplained hyperferritinemia", Haematologica, 94, 307, 10.3324/haematol.2008.005405 · DOI
  190. Jensen, 2010, Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron, Magn. Reson. Med., 63, 1201, 10.1002/mrm.22273 · DOI
  191. Wu, 2010, Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron, Annal. N. Y. Acad. Sci., 1202, 115, 10.1111/j.1749-6632.2010.05587.x · DOI
  192. Kruer, 2012, Neuroimaging features of neurodegeneration with brain iron accumulation, AJNR. Am. J. Neuroradiol., 33, 407, 10.3174/ajnr.A2677 · DOI · Paper page
  193. Acosta-Cabronero, 2013, In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease, PloS One, 8, e81093, 10.1371/journal.pone.0081093 · DOI · Paper page
  194. Qin, 2011, Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping, J. Huazhong Univ. Sci. Technol. Med. Sci., 31, 578, 10.1007/s11596-011-0493-1 · DOI
  195. Zhu, 2009, Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease, Radiology, 253, 497, 10.1148/radiol.2532082324 · DOI · Paper page
  196. Derry, 2017, Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's disease, Brain, 140, 2069, 10.1093/brain/awx167 · DOI
  197. Lavados, 2008, Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron, J. Alzheimers Dis., 13, 225, 10.3233/JAD-2008-13211 · DOI · Paper page
  198. Tao, 2014, Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis, J. Alzheimers. Dis., 42, 679, 10.3233/JAD-140396 · DOI · Paper page
  199. Smith, 2010, Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment, J. Alzheimers. Dis., 19, 363, 10.3233/JAD-2010-1239 · DOI · Paper page
  200. Ayton, 2017, Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline, Brain, 140, 2112, 10.1093/brain/awx137 · DOI · Paper page

200 of 334 shown

Cited by

See all 155

Metadata

Authors
Morris, G., Berk, M., Carvalho, A. F., Maes, M., Walker, A. J., & Puri, B. K.
Venue
Behavioural Brain Research
Publisher
Elsevier BV
Published
2018-04
Volume
341
Pages
154-175
ISSN
0166-4328 (ISSN-L)
OpenAlex
W2780739174
Cited by
155
References
94
FWCI
10.33
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
National Health and Medical Research Council (NHMRC) (1059660)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.